HPV Self-Sampling for Cervical Cancer Screening Among Transgender Men and Transmasculine Individuals

Completed · Not applicable

Conditions studied: Cervical Cancer Screening

In brief

The proposed study will examine the implementation of a Human Papillomavirus (HPV) self-sampling intervention for unscreened and under-screened transgender men and transmasculine individuals living in South Florida. The study will enroll participants to receive this cervical cancer screening intervention in community venues. The purpose of this study is to pilot the self-sampler for feasibility and acceptability within this underserved population.

Key facts

Study ID

NCT03222817

Run by

University of Miami

People needed

10

Starts

2018-05-12

Expected to finish

2018-10-17

Last updated by the study team

2019-05-03

Who can join

Age: 25 and older, up to 65. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Self-identify as transgender male or as transmasculine
• Assigned female sex at birth
• English speaking
• ages 25-65 years
• report not having had a pap smear in the last three years
• if age 30 and over, report not having a Pap smear/HPV co-test in the past 5 years

You may not qualify if…

• • Those who report having had a hysterectomy
• Those who report having history of cervical cancer
• Adults unable to consent
• Those who are pregnant
• Prisoners

Where it is running

• University of Miami — Miami, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.